Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news:

CBD

CBA calls for clear federal regulations relation to OTC sales of CBD products

In a letter to the acting commissioner of the FDA, the Consumer Brands Association (CBA) urges the federal agency to provide clear regulations relating to over-the-counter sales of CBD products. The CBA, which includes corporations like Coca-Cola, PepsiCo and Kellogg, says CBD is entering the U.S. markets through companies that are ignoring the FDA’s policy banning the substance from foods, beverages and dietary supplements and only allowing it in pharmaceuticals. In fact, the CBA estimates one-fourth of Americans have tried CBD products in spite of the sanctions. The association says it’s disappointed by the ongoing double standard and urges the FDA to take stronger action.  Hemp Industry Daily
Related:
CBA calls on FDA for stricter oversight, regulation of CBD products, without which ‘misconceptions and misunderstandings will cripple CBD’s potential before it can prove its value’ – Food Navigator-USA.com

Hemp

Hemp growers in Canada predict it’ll be $800M industry by 2030

Health Canada, the federal agency that licenses and regulates the hemp industry in Canada, estimates that 50,000 acres of farmland was given over to the crop last year, nearly a 10-fold increase in acreage from 1998. Industry insiders would like to see that number increase by a factor of 10 again in the next decade. The key, they say, is whole-plant utilization. While the extraction of CBD from hemp seed is a mature industry in Canada, value-added capacity is slowly being ratcheted up with decortication facilities planned for the western provinces, where the bulk of hemp farms exist. Canadian hemp exports exceeded $88 million (C$110 million) in 2019 and the non-profit Alberta Hemp Alliance says that could grow to $800 million (C$1 billion) by 2030.  The Canadian Press

Federal legislative committee expresses concern about allowable THC levels in hemp

In a response to the draft of a spending bill for the fiscal year 2022 for Agriculture, Rural Development, Food and Drug Administration and Related Agencies, the House Appropriations Committee reported the allowable THC limit for hemp should be reconsidered. The committee states the 0.3% limit is arbitrary and may not be supported by science. It adds the limit may pose a burden on hemp producers, a point supported by Cannovia CEO Brian Baum who notes the plants readily exceed the THC limit during certain stages of development and constant testing is required to ensure products don’t exceed regulatory tolerances. Many in the industry support Switzerland’s THC limit of 1% for hemp.  Hemp Grower

*                      *                      *

Subscribe here to Kelley Drye’s Cannabis Law Update blog to receive future roundups and blog posts.